Shunichi Sugawara

机构：Sendai Kousei Hospital · ORCID：0000-0002-3427-4558

发表论文 409 篇 · 总被引 25996 次 · h-index 51

代表论文

• A Pooled Analysis of Datopotamab Deruxtecan in Patients With EGFR-Mutated NSCLC (2025 · Journal of Thoracic Oncology · 被引 49)
• Five-Year Survival Outcomes With Atezolizumab After Chemotherapy in Resected Stage IB-IIIA Non–Small Cell Lung Cancer (IMpower010): An Open-Label, Randomized, Phase III Trial (2025 · Journal of Clinical Oncology · 被引 44)
• Activity and safety of atezolizumab plus carboplatin and paclitaxel in patients with advanced or recurrent thymic carcinoma (MARBLE): a multicentre, single-arm, phase 2 trial (2025 · The Lancet Oncology · 被引 20)
• Radiotherapy-free pembrolizumab combined with chemotherapy for locally advanced non-small-cell lung cancer with PD-L1 tumour proportion score of 50% or higher (Evolution trial): a multicentre, single-arm, phase 2 study (2025 · The Lancet Oncology · 被引 5)
• MA02.02 Updated Efficacy and Safety of Taletrectinib in Patients With ROS1+ Non-Small Cell Lung Cancer: The Global TRUST-II Study (2025 · Journal of Thoracic Oncology · 被引 3)
• Biological impact of chemotherapy during treatment with EGFR tyrosine kinase inhibitors for non-small cell lung cancer positive for EGFR activating mutations (2025 · Lung Cancer · 被引 3)